SCHEMBL10014743

SCHEMBL10014743

[C-]#[N+]c1c(F)ccc(-c2cccc(OC)c2)c1F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1C3 P42330 3/20 0.45
▸ AKR1C2 P52895 3/20 0.45
▸ KDM1A O60341 2/20 0.43
▸ KDM1B Q8NB78 2/20 0.43
▸ CYP1A2 P05177 3/20 0.43
▸ CYP3A4 P08684 3/20 0.43
▸ CYP2D6 P10635 3/20 0.43
▸ CYP2C19 P33261 3/20 0.43
▸ CYP1A1 P04798 2/20 0.43
▸ CYP2E1 P05181 2/20 0.43
▸ CYP2C8 P10632 2/20 0.43
▸ CYP2A6 P11509 2/20 0.43
▸ CYP2C9 P11712 2/20 0.43
▸ CYP4B1 P13584 2/20 0.43
▸ CYP2B6 P20813 2/20 0.43
▸ CYP3A5 P20815 2/20 0.43
▸ CYP2A7 P20853 2/20 0.43
▸ CYP3A7 P24462 2/20 0.43
▸ CYP2F1 P24903 2/20 0.43
▸ CYP2C18 P33260 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10014736 0.81 AKR1C3 (0.42) AKR1C3AKR1C2RPS6KA3CLK4DYRK1A
SCHEMBL10014741 0.79 AKR1C3 (0.49) AKR1C3AKR1C2KDM1AKDM1BCYP1A2
SCHEMBL10014728 0.77 HSD17B14 (0.36) ALDH1A1BRD4HSD17B10
SCHEMBL12750060 0.75 CCR1 (0.50) KDM1ACYP17A1CYP11B1CYP11B2
SCHEMBL10014739 0.72 AKR1C3 (0.58) AKR1C3AKR1C2KDM1AKDM1BCYP1A2
SCHEMBL29279322 0.72 KDM1A (0.49) AKR1C3AKR1C2KDM1AKDM1BCYP1A2
SCHEMBL28189326 0.72 CYP1A2 (0.54) AKR1C3AKR1C2KDM1AKDM1BCYP1A2
SCHEMBL24330236 0.72 TDO2 (0.49) AKR1C3AKR1C2KDM1AKDM1BCYP1A2
SCHEMBL21586175 0.72 CYP1A1 (0.46) AKR1C3AKR1C2KDM1AKDM1BCYP1A2
SCHEMBL30516664 0.72 CASR (0.58) AKR1C3AKR1C2KDM1AKDM1BCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120025177-A1 Phosphorescent light-emitting iridium complex containing pyridyltriazole ligand SOLVAY SA (BE) 2012-02-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120025177-A1 Phosphorescent light-emitting iridium complex containing pyridyltriazole ligand PPIP5K2, HPRT1, PHPT1 AKR1C3 3856/4885AKR1C2 4199/4885KDM1A 3954/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback